Concepedia

H. Bischoff

HB

Statistics

Publications

6

Citations

189

H-Index

6

Active since

1985

Affiliations

Institut de Cancérologie Strasbourg(Current)

Centre Georges François Leclerc

Centre Hospitalier de la Côte Basque

Centre Hospitalier Universitaire de Limoges

Centre François Baclesse

H. Bischoff is an author at Institut de Cancérologie Strasbourg specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1985–2024

6

Publications

6

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

François Poumeaud, Mathilde Morisseau, Luc Cabel et al. · British Journal of Cancer · 2024 · 50 citations · Full text

, , +17

Efficacy of ?-diketonato complexes of titanium, zirconium, and hafnium against chemically induced autochthonous colonic tumors in rats

H. Bischoff, Massimo Berger, Bernhard K. Keppler et al. · Journal of Cancer Research and Clinical Oncology · 1987 · 45 citations · Full text

, , +6

FP13.02 Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189

Jhanelle E. Gray, Delvys Rodríguez‐Abreu, Steven Powell et al. · Journal of Thoracic Oncology · 2021 · 39 citations · Full text

, , +13

Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors.

Michael Berger, H. Bischoff, E Fritschi et al. · PubMed · 1985 · 28 citations

, , +13

Oral ifosfamide-mesna: A clinical investigation in advanced non-small-cell lung cancer

C. Manegold, H. Bischoff, J.R. Fischer et al. · Annals of Oncology · 1992 · 14 citations

, , +10

1–5 of 6